Multiple chemical sensitivity: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Pierre-Alain Gouanvic
(New page: '''Multiple chemical sensitivities''', also known as environmental intolerances, is a poorly understood and often disputed syndrome which is described using the following criteria: * The ...)
 
imported>Pierre-Alain Gouanvic
No edit summary
Line 6: Line 6:
* responses occur to multiple chemically unrelated substances; and  
* responses occur to multiple chemically unrelated substances; and  
* symptoms involve multiple organ systems.<ref name="pmid10444033">{{cite journal |author= |title=Multiple chemical sensitivity: a 1999 consensus |journal=Arch. Environ. Health |volume=54 |issue=3 |pages=147–9 |year=1999 |pmid=10444033 |doi=}}</ref>
* symptoms involve multiple organ systems.<ref name="pmid10444033">{{cite journal |author= |title=Multiple chemical sensitivity: a 1999 consensus |journal=Arch. Environ. Health |volume=54 |issue=3 |pages=147–9 |year=1999 |pmid=10444033 |doi=}}</ref>
==Epidemiology==
''(in progress)''


==Genetic basis==
==Genetic basis==
People diagnosed using the 1999 consensus statement criteria<ref name="pmid10444033"/> have significant differences in some drug-metabolizing enzymes and other enzymes involved in detoxication.<ref name="pmid15256524">{{cite journal |author=McKeown-Eyssen G, Baines C, Cole DE, ''et al'' |title=Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR |journal=International journal of epidemiology |volume=33 |issue=5 |pages=971–8 |year=2004 |pmid=15256524 |doi=10.1093/ije/dyh251}}</ref>
People diagnosed using the 1999 consensus statement criteria<ref name="pmid10444033"/> have significant differences in some drug-metabolizing enzymes and other enzymes involved in detoxication.<ref name="pmid15256524">{{cite journal |author=McKeown-Eyssen G, Baines C, Cole DE, ''et al'' |title=Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR |journal=International journal of epidemiology |volume=33 |issue=5 |pages=971–8 |year=2004 |pmid=15256524 |doi=10.1093/ije/dyh251}}</ref>
These findings, which require replication, point to an unequivocal somatic and toxic basis to multiple chemical sensitivities.
These findings, which require replication, point to an unequivocal somatic and toxic basis to multiple chemical sensitivities.
==Immunological basis==
In a case control study involving 417 persons (223 cases, 194 controls), lymphocyte count was found to be consistent low in victims of MCS.<ref name="pmid15347780">{{cite journal |author=Baines CJ, McKeown-Eyssen GE, Riley N, ''et al'' |title=Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures |journal=Occupational medicine (Oxford, England) |volume=54 |issue=6 |pages=408–18 |year=2004 |pmid=15347780 |doi=10.1093/occmed/kqh083 |issn=}}</ref>


==References==
==References==

Revision as of 18:25, 17 November 2007

Multiple chemical sensitivities, also known as environmental intolerances, is a poorly understood and often disputed syndrome which is described using the following criteria:

  • The symptoms are reproducible with repeated chemical exposure;
  • the condition is chronic;
  • low levels of exposure (lower than previously tolerated) result in manifestations of the syndrome;
  • the symptoms improve or resolve when the incitants are removed;
  • responses occur to multiple chemically unrelated substances; and
  • symptoms involve multiple organ systems.[1]

Epidemiology

(in progress)

Genetic basis

People diagnosed using the 1999 consensus statement criteria[1] have significant differences in some drug-metabolizing enzymes and other enzymes involved in detoxication.[2] These findings, which require replication, point to an unequivocal somatic and toxic basis to multiple chemical sensitivities.

Immunological basis

In a case control study involving 417 persons (223 cases, 194 controls), lymphocyte count was found to be consistent low in victims of MCS.[3]

References

  1. 1.0 1.1 (1999) "Multiple chemical sensitivity: a 1999 consensus". Arch. Environ. Health 54 (3): 147–9. PMID 10444033[e]
  2. McKeown-Eyssen G, Baines C, Cole DE, et al (2004). "Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR". International journal of epidemiology 33 (5): 971–8. DOI:10.1093/ije/dyh251. PMID 15256524. Research Blogging.
  3. Baines CJ, McKeown-Eyssen GE, Riley N, et al (2004). "Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures". Occupational medicine (Oxford, England) 54 (6): 408–18. DOI:10.1093/occmed/kqh083. PMID 15347780. Research Blogging.